NPI: 1265539498 · LOUISVILLE, KY 40207 · Rehabilitation Clinic/Center · NPI assigned 09/20/2006
Authorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | CARRICO, RICHARD (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 09/20/2006 |
Other providers sharing the same authorized official: CARRICO, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 114,002 | $5.11M |
| 2019 | 125,974 | $5.74M |
| 2020 | 128,768 | $5.54M |
| 2021 | 170,748 | $8.63M |
| 2022 | 188,196 | $10.06M |
| 2023 | 239,333 | $13.88M |
| 2024 | 205,476 | $13.46M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 26,309 | 21,608 | $6.48M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 31,705 | 27,520 | $5.41M |
| G0378 | Hospital observation service, per hour | 9,377 | 7,596 | $4.22M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,469 | 8,224 | $3.81M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,461 | 6,649 | $2.86M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 6,449 | 5,679 | $2.69M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4,678 | 2,061 | $1.77M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,296 | 1,077 | $1.59M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,256 | 6,410 | $1.41M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,399 | 2,753 | $1.40M |
| C1776 | Joint device (implantable) | 372 | 297 | $1.35M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,728 | 3,214 | $1.32M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,307 | 6,578 | $991K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23,036 | 6,964 | $990K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,901 | 5,352 | $907K |
| 93017 | 3,514 | 3,128 | $901K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3,471 | 2,930 | $814K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,362 | 1,870 | $740K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 32,298 | 18,088 | $697K |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,661 | 13,294 | $696K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,848 | 2,358 | $692K |
| 59025 | Fetal non-stress test | 7,455 | 4,953 | $679K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 25,143 | 20,591 | $675K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 10,346 | 9,020 | $602K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,942 | 4,523 | $591K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12,536 | 7,573 | $547K |
| 80053 | Comprehensive metabolic panel | 69,891 | 45,664 | $542K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,607 | 1,787 | $536K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,242 | 960 | $520K |
| 96376 | 8,977 | 4,760 | $487K | |
| 71250 | 2,752 | 2,435 | $416K | |
| 71045 | Radiologic examination, chest; single view | 12,243 | 10,115 | $342K |
| 93458 | 276 | 127 | $340K | |
| 36415 | Collection of venous blood by venipuncture | 68,974 | 36,723 | $328K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 59,723 | 45,918 | $314K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,950 | 1,607 | $312K |
| 93971 | 1,750 | 1,600 | $296K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,278 | 1,167 | $294K |
| 76819 | Fetal biophysical profile; without non-stress testing | 3,040 | 1,603 | $293K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,106 | 3,000 | $288K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8,159 | 6,827 | $286K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 10,246 | 8,290 | $279K |
| 93976 | 2,588 | 2,336 | $272K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,431 | 2,051 | $255K |
| 71046 | Radiologic examination, chest; 2 views | 10,385 | 8,903 | $254K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 11,355 | 5,149 | $238K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 836 | 765 | $237K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,699 | 2,499 | $231K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5,868 | 1,866 | $226K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 2,124 | 1,754 | $223K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,724 | 2,280 | $211K |
| J2785 | Injection, regadenoson, 0.1 mg | 1,285 | 1,166 | $206K |
| 72110 | 1,999 | 1,626 | $202K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,745 | 1,636 | $185K |
| C1769 | Guide wire | 1,862 | 1,643 | $183K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,537 | 1,983 | $181K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2,331 | 1,814 | $174K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,280 | 1,932 | $170K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 313 | 273 | $168K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,376 | 13,672 | $165K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 454 | 419 | $154K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3,746 | 1,142 | $154K |
| 43775 | 55 | 52 | $152K | |
| 90791 | Psychiatric diagnostic evaluation | 2,993 | 2,703 | $152K |
| 83880 | 5,627 | 4,813 | $151K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 3,773 | 3,468 | $151K |
| 84484 | 17,770 | 11,387 | $150K | |
| J3490 | Unclassified drugs | 1,566 | 1,229 | $144K |
| 80048 | Basic metabolic panel (calcium, ionized) | 19,989 | 13,467 | $138K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 262 | 198 | $136K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 321 | 264 | $135K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 467 | 418 | $129K |
| 70496 | 424 | 325 | $126K | |
| 73560 | 2,103 | 1,619 | $126K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,597 | 2,135 | $123K |
| 73630 | 1,504 | 1,305 | $118K | |
| 76642 | 1,186 | 1,116 | $113K | |
| 73030 | 1,788 | 1,337 | $112K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,820 | 719 | $110K |
| 97161 | 3,092 | 2,226 | $103K | |
| 93970 | 441 | 394 | $98K | |
| 74018 | 1,759 | 1,289 | $96K | |
| C1889 | Implantable/insertable device, not otherwise classified | 933 | 541 | $96K |
| 88307 | 1,478 | 1,046 | $93K | |
| 73610 | 1,132 | 949 | $89K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 951 | 802 | $84K |
| J2704 | Injection, propofol, 10 mg | 18,172 | 13,999 | $80K |
| 76536 | 869 | 807 | $80K | |
| 84443 | Thyroid stimulating hormone (TSH) | 6,409 | 5,696 | $79K |
| 47563 | 69 | 41 | $78K | |
| 97162 | 3,218 | 1,743 | $77K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,337 | 1,177 | $77K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,708 | 1,313 | $76K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9,904 | 7,118 | $76K |
| 88304 | 2,942 | 2,161 | $75K | |
| 97113 | 893 | 249 | $75K | |
| 85027 | 14,777 | 11,588 | $74K | |
| 76830 | Ultrasound, transvaginal | 867 | 781 | $72K |
| 84703 | 13,524 | 12,134 | $71K | |
| 83690 | 15,017 | 12,955 | $69K | |
| 0002A | 2,280 | 2,178 | $65K | |
| 73130 | 755 | 643 | $64K | |
| 0001A | 2,556 | 2,350 | $63K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,616 | 2,353 | $62K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 842 | 775 | $62K |
| 80061 | Lipid panel | 6,095 | 4,154 | $61K |
| 70498 | 268 | 228 | $61K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,527 | 2,161 | $58K |
| 72141 | 197 | 180 | $56K | |
| 19318 | 13 | 12 | $55K | |
| 82948 | 7,254 | 2,499 | $54K | |
| 84145 | 2,851 | 2,356 | $53K | |
| 82962 | 12,600 | 4,925 | $52K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 106 | 67 | $51K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 495 | 238 | $50K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 446 | 418 | $50K |
| 82077 | 3,921 | 3,263 | $50K | |
| 93325 | 612 | 576 | $49K | |
| 84112 | 654 | 564 | $49K | |
| 73502 | 868 | 669 | $46K | |
| 83735 | 9,360 | 7,085 | $45K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,885 | 1,733 | $45K |
| 27447 | 51 | 12 | $44K | |
| 77066 | Tomosynthesis, mammo | 507 | 405 | $43K |
| 72131 | 129 | 113 | $43K | |
| 95806 | 306 | 276 | $43K | |
| 74183 | 145 | 112 | $42K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 13,688 | 8,490 | $42K |
| 81001 | 17,071 | 14,587 | $42K | |
| 83605 | 5,151 | 3,827 | $41K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 5,337 | 4,750 | $40K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,895 | 1,742 | $40K |
| 88342 | 1,221 | 864 | $40K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,330 | 1,225 | $39K |
| 82607 | 3,595 | 2,719 | $39K | |
| 95886 | 159 | 137 | $39K | |
| 87040 | 5,255 | 2,420 | $38K | |
| 58661 | 55 | 41 | $37K | |
| 85610 | 11,198 | 8,013 | $37K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 15,686 | 10,250 | $36K |
| 82728 | 3,713 | 2,862 | $36K | |
| 76820 | 687 | 266 | $35K | |
| 70491 | 152 | 119 | $35K | |
| 96367 | 395 | 282 | $34K | |
| 94664 | 1,220 | 448 | $34K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,039 | 5,219 | $34K |
| 88341 | 235 | 181 | $34K | |
| 72100 | 395 | 338 | $33K | |
| 86850 | 4,036 | 3,126 | $33K | |
| 81025 | 6,232 | 5,651 | $32K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 147 | 141 | $32K |
| 76942 | 504 | 425 | $31K | |
| 82746 | 2,658 | 2,406 | $31K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,436 | 3,291 | $31K |
| 84702 | 3,084 | 2,524 | $31K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,730 | 1,481 | $28K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 878 | 752 | $26K |
| 0100U | 334 | 209 | $26K | |
| 73562 | 250 | 210 | $26K | |
| 85379 | 3,698 | 3,380 | $26K | |
| 73110 | 256 | 214 | $25K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,576 | 3,116 | $24K |
| 81003 | 11,646 | 10,324 | $22K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,536 | 3,016 | $22K |
| 80050 | General health panel | 628 | 569 | $22K |
| 72050 | 300 | 242 | $22K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 88 | 76 | $20K |
| 84439 | 3,105 | 2,581 | $20K | |
| 87070 | 3,186 | 2,008 | $19K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 73 | 65 | $19K |
| 76775 | 112 | 105 | $19K | |
| J1756 | Injection, iron sucrose, 1 mg | 420 | 158 | $18K |
| 84425 | 1,029 | 945 | $18K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 218 | 201 | $18K |
| 64447 | 33 | 26 | $18K | |
| 77049 | 53 | 49 | $18K | |
| 70486 | 63 | 57 | $18K | |
| 87081 | 2,859 | 2,625 | $17K | |
| 85730 | 3,879 | 3,150 | $17K | |
| 83921 | 957 | 877 | $16K | |
| 77080 | 356 | 305 | $16K | |
| 83540 | 3,064 | 2,725 | $15K | |
| 99152 | 381 | 319 | $15K | |
| 84466 | 1,665 | 1,444 | $15K | |
| 84100 | 1,626 | 1,043 | $15K | |
| 90715 | 512 | 492 | $15K | |
| 87186 | 2,115 | 1,695 | $14K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 13,053 | 10,397 | $13K |
| 58563 | 12 | 12 | $13K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,283 | 1,973 | $12K |
| 0004A | 502 | 483 | $12K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,413 | 731 | $12K |
| 58558 | 12 | 12 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 26,715 | 19,205 | $11K |
| 94761 | 1,046 | 412 | $11K | |
| 86900 | 4,251 | 3,619 | $10K | |
| J1790 | Injection, droperidol, up to 5 mg | 1,669 | 1,417 | $10K |
| 86901 | 4,165 | 3,608 | $10K | |
| 84134 | 810 | 727 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 892 | 844 | $10K |
| 86140 | 2,619 | 2,110 | $10K | |
| 73590 | 112 | 94 | $10K | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 2,420 | 1,773 | $9K |
| 36416 | 4,241 | 1,734 | $9K | |
| 97535 | Self-care/home management training, each 15 minutes | 433 | 303 | $9K |
| 64415 | 51 | 24 | $9K | |
| 82803 | 473 | 347 | $9K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 657 | 275 | $8K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,558 | 2,760 | $8K |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 1,504 | 1,070 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 658 | 594 | $8K |
| 93356 | 319 | 302 | $8K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 10,392 | 8,574 | $8K |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,077 | 1,445 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 623 | 559 | $8K |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 1,736 | 738 | $8K |
| 82550 | 1,575 | 1,200 | $8K | |
| 87205 | 2,483 | 1,980 | $8K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,337 | 944 | $8K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,431 | 2,228 | $8K |
| 87634 | 107 | 91 | $7K | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,155 | 416 | $7K |
| 73221 | 25 | 24 | $7K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 329 | 208 | $7K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,650 | 1,250 | $7K |
| 72072 | 88 | 63 | $7K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,306 | 685 | $7K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,256 | 983 | $6K |
| 71271 | 97 | 95 | $6K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 984 | 808 | $6K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,166 | 965 | $6K |
| 73070 | 77 | 63 | $6K | |
| 80074 | 139 | 119 | $5K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 919 | 778 | $5K |
| 82570 | 1,158 | 986 | $5K | |
| 71101 | 92 | 66 | $5K | |
| J3411 | Injection, thiamine hcl, 100 mg | 1,300 | 712 | $5K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,584 | 1,194 | $5K |
| 85014 | 1,655 | 730 | $5K | |
| 85652 | 2,486 | 2,119 | $5K | |
| 76825 | 39 | 37 | $5K | |
| 77065 | Tomosynthesis, mammo | 78 | 55 | $5K |
| 87077 | 683 | 581 | $5K | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 2,913 | 2,614 | $5K |
| J1644 | Injection, heparin sodium, per 1000 units | 2,525 | 1,394 | $4K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 19 | 12 | $4K |
| 93922 | 50 | 43 | $4K | |
| 87147 | 622 | 362 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 10,225 | 8,481 | $4K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,684 | 1,311 | $4K |
| 84156 | 926 | 748 | $4K | |
| 78226 | 16 | 13 | $4K | |
| 87507 | 16 | 12 | $4K | |
| 80143 | 226 | 194 | $4K | |
| 74300 | 46 | 41 | $3K | |
| 72040 | 39 | 28 | $3K | |
| 87075 | 392 | 323 | $3K | |
| 88312 | 278 | 206 | $3K | |
| 87581 | 172 | 162 | $3K | |
| 87486 | 175 | 163 | $3K | |
| 76818 | 27 | 25 | $3K | |
| 87210 | 786 | 748 | $3K | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 231 | 195 | $3K |
| 80179 | 193 | 166 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,910 | 3,008 | $3K |
| 85018 | 1,603 | 698 | $3K | |
| 0054A | 106 | 89 | $2K | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 653 | 488 | $2K |
| 86803 | 223 | 189 | $2K | |
| 93880 | 20 | 14 | $2K | |
| J3480 | Injection, potassium chloride, per 2 meq | 317 | 124 | $2K |
| 83013 | 36 | 34 | $2K | |
| 94726 | 41 | 36 | $2K | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 295 | 179 | $2K |
| J2060 | Injection, lorazepam, 2 mg | 2,114 | 1,568 | $2K |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,224 | 1,035 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,748 | 1,243 | $2K |
| 0399T | 61 | 45 | $2K | |
| 0011A | 79 | 73 | $2K | |
| 0012A | 69 | 67 | $2K | |
| C1726 | Catheter, balloon dilatation, non-vascular | 17 | 15 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 97 | 87 | $2K |
| 82784 | 93 | 81 | $1K | |
| 84132 | 420 | 281 | $1K | |
| 94060 | 12 | 12 | $1K | |
| 76827 | 40 | 37 | $1K | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 15 | 15 | $1K |
| 83970 | 39 | 36 | $1K | |
| 93246 | 15 | 14 | $1K | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 404 | 200 | $1K |
| 87015 | 225 | 121 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 294 | 179 | $1K |
| 88302 | 70 | 53 | $998.28 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 257 | 192 | $947.48 |
| 0124A | 36 | 34 | $915.20 | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 68 | 57 | $908.60 |
| 76801 | 21 | 14 | $906.69 | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 28 | 24 | $861.17 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 469 | 394 | $856.98 |
| 97116 | 161 | 75 | $841.68 | |
| 84550 | 240 | 181 | $828.18 | |
| 87631 | 19 | 17 | $815.43 | |
| 84436 | 134 | 116 | $786.28 | |
| 82378 | 64 | 52 | $785.44 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 17 | 14 | $772.20 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 94 | 82 | $763.15 |
| 83615 | 179 | 143 | $677.45 | |
| 36600 | 36 | 29 | $639.18 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 211 | 136 | $637.73 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,274 | 982 | $632.21 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 74 | 50 | $630.39 |
| 97012 | 76 | 12 | $552.49 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 391 | 335 | $516.17 |
| 81002 | 420 | 355 | $506.11 | |
| 84479 | 75 | 70 | $479.30 | |
| 97165 | 16 | 13 | $467.97 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 265 | 170 | $467.45 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 539 | 450 | $464.22 |
| 97166 | 12 | 12 | $404.05 | |
| C1758 | Catheter, ureteral | 29 | 25 | $367.86 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 553 | 414 | $356.00 |
| 99153 | Mod sedat endo service >5yrs | 13 | 12 | $344.37 |
| 0003A | 24 | 22 | $333.68 | |
| 87220 | 126 | 121 | $303.35 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 70 | 64 | $293.16 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 236 | 172 | $289.20 |
| C1755 | Catheter, intraspinal | 74 | 40 | $256.62 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 42 | 39 | $243.68 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 13 | 12 | $236.90 |
| 86780 | 29 | 27 | $225.08 | |
| 84446 | 18 | 12 | $184.61 | |
| 84597 | 18 | 12 | $181.05 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 20 | 12 | $176.82 |
| Q9961 | High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml | 40 | 37 | $176.67 |
| 86308 | 42 | 38 | $176.12 | |
| 80306 | 12 | 12 | $165.74 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 92 | 73 | $162.49 |
| 84630 | 19 | 13 | $150.27 | |
| 84590 | 18 | 12 | $149.36 | |
| 82010 | 17 | 12 | $147.06 | |
| G0008 | Administration of influenza virus vaccine | 16 | 14 | $109.28 |
| 82731 | 14 | 13 | $100.93 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 16 | 13 | $93.21 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 44 | 43 | $87.65 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 20 | 18 | $75.60 |
| J1953 | Injection, levetiracetam, 10 mg | 90 | 29 | $74.82 |
| J1940 | Injection, furosemide, up to 20 mg | 64 | 29 | $74.74 |
| 86592 | 19 | 16 | $72.39 | |
| 90686 | 16 | 14 | $55.11 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 36 | 26 | $19.54 |
| 99499 | 38 | 37 | $0.00 |